Lysosomal dysfunction & autophagy GBA-targeted therapy
-
GT-02287 restores GCase enzyme activity, which is intended to reduce buildup of toxic alpha-synuclein clumps caused by impaired lysosomal protein clearance.
GT-02287 is designed to bind to GCase and restore its activity, thereby preventing the formation of toxic protein clumps and slowing the progression of Parkinson's.